Pinnacle Treatment Centers Appoints Brian Lantier as Chief Executive Officer GlobeNewswire January 07, 2026 Mount Laurel, NJ, Jan. 07, 2026 (GLOBE NEWSWIRE) — Pinnacle Treatment Centers, a leading provider of affordable, accessible addiction treatment services, has announced the appointment of Brian Lantier as its new Chief Executive Officer. Lantier succeeds Joe Pritchard, who served as […]

Austin, Texas, Jan. 07, 2026 (GLOBE NEWSWIRE) — Rent with Clara, the renter-first tenant screening platform built for independent landlords, today announced the launch of bank connection verification, a real-time income validation feature that addresses the growing threat of rental application fraud. Rent with Clara Mission Statement With nearly 6.4% of rental applications containing fraudulent

Rent with Clara Launches Multi-Layer Bank Verification to Combat Rising Rental Application Fraud Independent landlords gain enterprise-level fraud protection as the platform adds real-time income validation to its comprehensive screening suite. GlobeNewswire January 07, 2026 Austin, Texas, Jan. 07, 2026 (GLOBE NEWSWIRE) — Rent with Clara, the renter-first tenant screening platform built for independent landlords,

Riyadh, Saudi Arabia, Jan. 07, 2026 (GLOBE NEWSWIRE) — Professor Svetlana Mojsov was announced this year's King Faisal Prize in Medicine laureate for her groundbreaking discoveries that are reshaping how we treat obesity, and Professor Carlos Kenig was announced this year's King Faisal Prize in Science laureate in the field of Mathematics for revolutionizing our

(Nasdaq First North Finland:HRTIS), Herantis Pharma Plc – Company release Inside information: Herantis Pharma – Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease Biomarker data show that HER-096 modulates Parkinson's disease-relevant pathways, consistent with preclinical data, and supporting further clinical development HER-096 exposure was associated with

Pioneering Scientist Behind Revolutionary Weight-Loss Drugs and Leading Mathematician Honored with 2026 King Faisal Prize Professor Svetlana Mojsov and Professor Carlos Kenig, among other eminent figures, were selected to win the 48th session of the Prize GlobeNewswire January 07, 2026 Riyadh, Saudi Arabia, Jan. 07, 2026 (GLOBE NEWSWIRE) — Professor Svetlana Mojsov was announced this

NEW YORK CITY, NY / ACCESS Newswire / January 7, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against F5, Inc. ("F5" or the "Company") (NASDAQ:FFIV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Herantis Pharma – Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease GlobeNewswire January 07, 2026 Herantis Pharma Plc – Company release Inside information: Herantis Pharma – Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease Biomarker data show

NEW YORK CITY, NY / ACCESS Newswire / January 7, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Agilon Health, Inc. ("Agilon" or the "Company") (NYSE:AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

NEW YORK CITY, NY / ACCESS Newswire / January 7, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Smartsheet Inc. ("Smartsheet" or the "Company") (NYSE:SMAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged